COPD Emerging Therapies - Only a Breath Away
This activity is supported by an educational grant from Verona Pharma, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Verona Pharma, Inc.
Activity Description
Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease that is often underdiagnosed and undertreated, negatively impacting patients’ quality of life. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines are revised annually and represent an important repository of evidenced-based diagnosis and treatment recommendations, but they remain underutilized in clinical practice. Additionally, as the therapeutic landscape for COPD continues to expand, many clinicians are challenged to stay up to date on emerging, investigational therapies in late-stage development. In this In Case You Missed program, experts summarize the current COPD guidelines, differentiate mechanisms of action for emerging treatments, and review the latest clinical evidence for novel targeted therapies in late-stage development. Faculty discuss key data presented at conferences during the past year on therapies with the potential to improve outcomes for patients with COPD.
Target Audience
The intended audience for this activity is pulmonologists, pharmacists, and other healthcare professionals involved in the management of patients with COPD.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Review the burden associated with COPD as well as current guidelines and treatment goals.
- Differentiate mechanisms of action for emerging treatments that have potential in improving outcomes for patients with COPD.
- Describe new clinical trial data on the safety and efficacy of novel targeted therapies in late-stage development that address the underlying pathways that cause COPD.
Activity Chair
MeiLan K. Han, MD, MS
Henry Sewall Endowed Professor
Chief, Pulmonary and Critical Care Medicine
University of Michigan
Ann Arbor, MI
Faculty
Igor Barjaktarevic, MD, PhD
Associate Professor
Medical Director, Liver Transplant Intensive Care Unit
UCLA Division of Liver and Pancreas Transplantation
Medical Director, COPD Program
Director of Critical Care Ultrasound
UCLA Division of Pulmonary and Critical Care Medicine
David Geffen School of Medicine at University of California Los Angeles
Los Angeles, CA
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is acceptable for 1.0 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-24-047-H01-P, effective 03/31/2024. This is a knowledge-based activity, and there is no fee to attend.
Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.
This enduring material is approved for 1 year from the date of original release, March 31, 2024, to March 30, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or Statement of Continuing Pharmacy Education Credit.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Igor Barjaktarevic, MD, PhD
Advisor: AstraZeneca, Grifols, Inhibrx, Sanofi and Regeneron, Verona
Independent Research Contractor: Aerogen, GE Healthcare, Theravance, Viatris
MeiLan K. Han, MD, MS
Consultant: Aerogen, Amgen, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Dev.Pro, GSK, Integrity, Merck, Mylan, Pulmonx, Regeneron, Roche, Sanofi, Teva, Verona
In Kind Research Support or Funds Paid to Institution: AstraZeneca, Biodesix, Boehringer Ingelheim, Gala, Novartis, Nuvaira, Sanofi, Sunovion
Data Safety Monitoring Boards (paid to institution): Medtronic, Novartis
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com